Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.

@article{Upadhyay2012LipidloweringTI,
  title={Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.},
  author={Ashish Upadhyay and Amy K Earley and Jenny L Lamont and Shana Haynes and Christoph Wanner and Ethan M. Balk},
  journal={Annals of internal medicine},
  year={2012},
  volume={157 4},
  pages={251-62}
}
BACKGROUND Lipid-lowering therapy is not widely used in persons with chronic kidney disease (CKD) despite a high burden of dyslipidemia and cardiovascular disease in this population. PURPOSE To synthesize evidence examining the effect of lipid-lowering therapy on clinical outcomes in persons with CKD. DATA SOURCES MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews from January 2000 through November 2011. STUDY SELECTION Randomized… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 12 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 59 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 45 references

281-6

  • Ioannidis JP. Effect of the statistical significance of resu completion, publication of randomized efficacy trials. JAMA. 1998, 279
  • [PMID: 9450711] VITAL STATISTICS More than 100…
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…